4.7 Article

Aerosolizable gold nano-in-micro dry powder formulations for theragnosis and lung delivery

Journal

INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 519, Issue 1-2, Pages 240-249

Publisher

ELSEVIER
DOI: 10.1016/j.ijpharm.2017.01.032

Keywords

Pulmonary delivery; Gold nanoparticles; Nano-in-micro; Supercritical CO2; Spray drying; Dry powder formulation; Lung cancer

Funding

  1. Associate Laboratory for Green Chemistry LAQV - national funds from FCT/MCTES [UID/QUI/50006/2013]
  2. ERDF [POCI-01-0145-FEDER - 007265, PTDC/EQU-EQU/116097/2009, PTDC/EBB-BIO/114320/2009, SFRH/BD/51584/2011, IF/00915/2014]
  3. Fundação para a Ciência e a Tecnologia [SFRH/BD/51584/2011, PTDC/EQU-EQU/116097/2009] Funding Source: FCT

Ask authors/readers for more resources

Functionalized gold nanoparticles (AuNPs) have been widely investigated as promising multifunctional nanosystems for the theragnosis of lung cancer, the most common and prominent cause of cancer death worldwide. Nevertheless, nanoparticles are not in appropriate sizes for an accurate deep lung delivery and the lack of locally and effective delivery of therapeutic biomolecules to the deep lungs is, in fact, the major cause of low therapeutic outcome. Herein we incorporate, for the first time, AuNPs into respirable microparticles. AuNPs were functionalized with biocompatible oligo(2-oxazoline)-based optically stable fluorescent coatings, and conjugated with a laminin peptide (YIGSR) for targeted lung cancer delivery. These POxylated AuNPs were then incorporated into a chitosan matrix by a clean process, supercritical CO2-assisted spray drying (SASD), yielding nano-in-micro clean ultrafine dry powder formulations. The engineered formulations present the adequate morphology and flowability to reach the deep lung, with aerodynamic sizes ranging 3.2-3.8 mu m, and excellent fine particle fraction (FPF) (FPF of 47% for CHT-bearing targeted AuNPs). The optimal biodegradation and release profiles enabled a sustained and controlled release of the embedded nanoparticles, with enhanced cellular uptake, opening new prospects for future lung theragnosis. (C) 2017 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available